PD128,907 Induces Ocular Hypotension in Rabbits: Involvement of D 2/D3 Dopamine Receptors and Brain Natriuretic Peptide

Journal of Ocular Pharmacology and Therapeutics

Volumn 20, Issue 1, 2004, Pages 15-23

  Chu, Eugenia ^a   Socci, Robin ^b   Chu, Teh Ching ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; BRAIN NATRIURETIC PEPTIDE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR FLOW; ARTICLE; CONTROLLED STUDY; DENERVATION; DOSE RESPONSE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; NONHUMAN; RABBIT; RECEPTOR UPREGULATION;

EID: 1042278015     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076804772745428     Document Type: Article

References (22)

1. Kebabian, J.W., and Caln, D.B. Multiple receptors for dopamine. Nature 277:93-96, 1979.
2. 3 dopamine receptor: Neurobiology and potential clinical relevance. Pharmacol. Rev. 49:231-252, 1997.
3. Landwehrmeyer, B., Mengod, G., and Palacios, J.M. Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur. J. Neurosci. 5:145-153, 1993.
4. Yamada, S., Yokoo, H., and Nishi, S. Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats. Brain Res. 648:176-179, 1994.
5. Shafer, R.A., and Levant, B. The D3 dopamine receptor in cellular and organismal function. Psychopharmacology 135:1-16, 1998.
6. Millan, M.J., Dekeyne, A., Rivet, J.M., Dubuffet, T., Lavielle, G., and Brocco, M. S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626. J. Pharmacol. Exp. Ther. 293:1063-1073, 2000.
7. Chu, E., Chu, T.C., and Potter, D.E. Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: A dopamine3 receptor agonist. J. Pharmacol. Exp. Ther. 293:710-716, 2000.
8. de Bold, A.J., Borenstein, H.B., Veress, A.T., and Sonnenberg, H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci. 28:89-94, 1981.
9. Levin, E.R., Gardner, D.G., and Samson, W.K. Mechanisms of disease: Natriuretic peptides. New Engl. J. Med. 339:321-328, 1998.
10. Chu, T.C., Han, P., Han, G., and Potter, D.E. Intraocular pressure lowering by S-allylmercaptocysteine in rabbits. J. Ocular. Pharmacol. Ther. 15:9-17, 1999.
11. 3H-NE, and cAMP levels in rabbit eyes. Pharmacology 65:155-161, 2002.
12. Russell, K.R., Moore, T.T., and Potter, D.E. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists. Neuropeptides 35:232-237, 2001.
13. Takashima, Y., Taniguchi, T., Yoshida, M., Haque, M.S., Yoshimura, N., and Honda, Y. Ocular hypotensive mechanism of intravitreally injected brain natriuretic peptide in rabbit. Invest. Ophthalmol. Vis. Sci. 37:2671-2677, 1996.
14. Fernandez-Durango, R., Moya, F.J., Ripodas, A., de Juan, J.A., Fernandez-Cruz A., and Bernal, R. Type B and type C natriuretic peptide receptors modulate intraocular pressure in the rabbit eye. Eur. J. Pharmacol. 364:107-113, 1999.
15. Chu, E., Chu, T.C., and Potter, D.E. Potential sites of action of TNPA: a dopamine-2 receptor agonist. Exp. Eye Res. 69:611-616, 1999.
16. Chu, T.C., Ogidigben, M.J., and Potter, D.E. Oxymetazoline: potential mechanisms of inhibitory effects on aqueous humor dynamics. Pharmacology 53:259-270, 1996.
17. Yablonski, M.E., Zimmerman, T.J., Waltman, S.R., and Becker, B. A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp. Eye Res. 27:135-142, 1978.
18. Brubaker, R. Measurement of aqueous flow by fluorophotometry. In Glaucoma, Ritch R, Schield MB, Krupin R, eds., Mosby, St. Louis, 1989, pp. 337-344.
19. Ogidigben, M., Chu, T.C., and Potter, D.E. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine. J. Pharmacol. Exp. Ther. 267:822-827, 1993.
20. Chu, T.C., and Potter, D.E. Omega conotoxin: A subtype-specific calcium channel ligand with therapeutic potential in glaucoma? Res. Commun. Pharmacol. Toxicol. 6:263-275, 2001.
21. Cole, D.F. Secretion of the aqueous humour. Exp Eye Res. 25 Suppl: 161-176, 1977.
22. Burke, J., and Schwartz, M. Preclinical evaluation of brimonidine. Surv. Ophthalmol. 41 Suppl 1:S9-18, 1996.